Literature DB >> 17131077

Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives.

Ilan Gottlieb1, Robson Macedo, David A Bluemke, João A C Lima.   

Abstract

Patients with non-ischemic cardiomyopathy often represent a diagnostic challenge, and correct etiologic diagnosis may influence outcomes. Lately, delayed myocardial enhancement MR imaging has been developed and is currently being used for a growing number of clinical applications. On delayed enhancement MR images, scarring or fibrosis appears as an area of high signal intensity, and the pattern by which this enhancement occurs in the myocardium allows distinction of many different pathologies. In nonischemic cardiomyopathy, the delayed enhancement usually does not occur in a coronary artery distribution and is often midwall rather than subendocardial or transmural. It could also guide myocardial biopsy to an affected area, increasing its yield. Cardiac magnetic resonance imaging has now a definitive role in clinical practice, and its capability to non-invasively provide high resolution images of the heart with good tissue characterization is redefining the understanding of the conditions that can adversely affect the myocardium.

Entities:  

Mesh:

Year:  2006        PMID: 17131077     DOI: 10.1007/s10741-006-0232-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  108 in total

1.  The paradox of exercise.

Authors:  B J Maron
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

Review 2.  Sudden cardiac death not related to coronary atherosclerosis.

Authors:  Elena Ladich; Renu Virmani; Allen Burke
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

3.  Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia.

Authors:  S Globits; G Kreiner; H Frank; G Heinz; U Klaar; B Frey; H Gössinger
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms.

Authors:  J A Lima; R M Judd; A Bazille; S P Schulman; E Atalar; E A Zerhouni
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

6.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

7.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

8.  Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.

Authors:  J G Shanes; J Ghali; M E Billingham; V J Ferrans; J J Fenoglio; W D Edwards; C C Tsai; J E Saffitz; J Isner; S Furner
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

9.  Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Work in progress.

Authors:  S Schaefer; R van Tyen; D Saloner
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

10.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

View more
  16 in total

1.  SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response.

Authors:  Michel Lalonde; David Birnie; Terrence D Ruddy; Robert A deKemp; Rob S B Beanlands; Richard Wassenaar; R Glenn Wells
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-09       Impact factor: 2.357

2.  Scar tissue and microvolt T-wave alternans.

Authors:  Karin Kraaier; Marlon A G M Olimulder; Michel A Galjee; Pascal F H M van Dessel; Job van der Palen; Arthur A M Wilde; Marcoen F Scholten
Journal:  Int J Cardiovasc Imaging       Date:  2014-02-23       Impact factor: 2.357

Review 3.  Cardiac magnetic resonance in clinical cardiology.

Authors:  Andreas Kumar; Rodrigo Bagur
Journal:  World J Cardiol       Date:  2015-01-26

4.  Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.

Authors:  Jeremy Collins; Cort Sommerville; Patrick Magrath; Bruce Spottiswoode; Benjamin H Freed; Keith H Benzuly; Robert Gordon; Himabindu Vidula; Dan C Lee; Clyde Yancy; James Carr; Michael Markl
Journal:  Circ Cardiovasc Imaging       Date:  2014-12-31       Impact factor: 7.792

5.  Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart.

Authors:  Erik B Schelbert; Li-Yueh Hsu; Stasia A Anderson; Bibhu D Mohanty; Syed M Karim; Peter Kellman; Anthony H Aletras; Andrew E Arai
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-16       Impact factor: 7.792

6.  T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.

Authors:  Neville Gai; Evrim B Turkbey; Saman Nazarian; Rob J van der Geest; Chia-Ying Liu; João A C Lima; David A Bluemke
Journal:  Magn Reson Med       Date:  2010-12-16       Impact factor: 4.668

7.  Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease.

Authors:  Steffen Bohl; Ralf Wassmuth; Hassan Abdel-Aty; André Rudolph; Daniel Messroghli; Rainer Dietz; Jeanette Schulz-Menger
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-16       Impact factor: 2.357

Review 8.  Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.

Authors:  Joseph M Pappachan; George I Varughese; Rajagopalan Sriraman; Ganesan Arunagirinathan
Journal:  World J Diabetes       Date:  2013-10-15

9.  Role of Cardiac MRI in the Assessment of Cardiomyopathy.

Authors:  Róisín B Morgan; Raymond Kwong
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

Review 10.  Myocardial T1 mapping: modalities and clinical applications.

Authors:  Christine L Jellis; Deborah H Kwon
Journal:  Cardiovasc Diagn Ther       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.